Alkermes plc.

Pharmaceutical Preparations·DUBLIN 4, L2·FY end 12/31·CIK 1520262

CEO Pay Ratio

30:1

Richard F. Pops

CEO Total Comp

$7.9M

Richard F. Pops

Median Employee

$266,757

Revenue

$1.5B

FY 2025

Net Income

$241.7M

FY 2025

Free Cash Flow

$480.3M

FY 2025

Net Margin

16.4%

Insider Net (180d)

-$1.5M

0 buys / 9 sales

CEO Pay Accountability

CEO comp as % of net income

3.28%

For every $1,000 of profit, $32.75 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$1.5B	$1.6B	$1.7B	$1.1B	$1.2B
Gross Profit	—	—	—	—	—	—
Operating Income	$254.0M	$420.6M	$414.1M	-$142.3M	-$29.3M
Net Income	$241.7M	$367.1M	$355.8M	-$158.3M	-$48.2M
Operating CF	$520.8M	$439.1M	$401.4M	$21.0M	$101.7M
Capex	$40.4M	$33.5M	$48.0M	$38.3M	$28.0M
Free Cash Flow	$480.3M	$405.6M	$353.3M	-$17.2M	$73.7M
Buybacks	—	$200.3M	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	17.2%	27.0%	24.9%	-12.8%	-2.5%
Net Margin	16.4%	23.6%	21.4%	-14.2%	-4.1%
FCF Margin	32.5%	26.0%	21.2%	-1.5%	6.3%
R&D / Revenue	22.0%	15.7%	16.3%	35.4%	34.6%
Effective Tax	17.1%	16.1%	-23.2%	5.4%	-22.5%
Debt / Equity	—	—	0.24	0.28	0.26
Buybacks / FCF	—	49.4%	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Richard F. PopsChief Executive Officer and Chairman	$1.3M	—	$5.0M	$1.6M	$17.5K	$7.9M
Blair C. JacksonExecutive Vice President, Chief Operating Officer;	$736.5K	$1.3M	$1.3M	$618.6K	$17.5K	$4.0M
Joshua Reed	$182.0K	$1.2M	$2.3M	$118.3K	$7.7K	$3.8M
Craig C. HopkinsonM.D.	$764.8K	$1.1M	$1.1M	$642.5K	$17.5K	$3.6M
David J. GaffinExecutive Vice President, Chief Legal Officer,	$684.5K	$1.1M	$1.1M	$575.0K	$17.5K	$3.5M
C. Todd NicholsSenior Vice President, Chief Commercial Officer	$614.9K	$866.7K	$861.2K	$430.4K	$17.5K	$2.8M